| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $0.3135 ▲ +4.50% | Yesterday | $0.2669 ▲ +12.40% | Tomorrow's Theriva Biologics Inc. Common Stock (TOVX) setup is anchored to $0.3000 and targets $0.3135 (+4.50%). The near-term read is upside; watch $0.3144 / $0.2615 because daily realized volatility is about 8.00%. |
Tomorrow's Theriva Biologics Inc. Common Stock (TOVX) setup is anchored to $0.3000 and targets $0.3135 (+4.50%). The near-term read is upside; watch $0.3144 / $0.2615 because daily realized volatility is about 8.00%. | ||||
| Week | $0.3313 ▲ +10.43% | Last Week | $0.3210 ▼ -6.54% | The 7-day Theriva Biologics Inc. Common Stock model moves from $0.3210 to $0.3313 (+10.43%). It gives upside momentum context for this stock, so breaks around $0.3144 / $0.2615 matter more than a single tick. |
The 7-day Theriva Biologics Inc. Common Stock model moves from $0.3210 to $0.3313 (+10.43%). It gives upside momentum context for this stock, so breaks around $0.3144 / $0.2615 matter more than a single tick. | ||||
| Month | $0.3532 ▲ +17.73% | Last Month | $0.3387 ▼ -11.43% | The 1-month Theriva Biologics Inc. Common Stock target is $0.3532 (+17.73%), compared with the live reference near $0.3000. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Theriva Biologics Inc. Common Stock target is $0.3532 (+17.73%), compared with the live reference near $0.3000. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $0.3816 ▲ +27.20% | Last Year | $0.4600 ▼ -34.78% | The 1-year Theriva Biologics Inc. Common Stock scenario points to $0.3816 (+27.20%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Theriva Biologics Inc. Common Stock scenario points to $0.3816 (+27.20%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $0.4466 ▲ +48.87% | 5 Years Ago | $133.73 ▼ -99.78% | The 5-year Theriva Biologics Inc. Common Stock view is $0.4466 (+48.87%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Theriva Biologics Inc. Common Stock view is $0.4466 (+48.87%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 0.8 | Bearish |
| MACD | 0.10 | Bullish |
| SMA 50 | $0.3139 | Mid |
| SMA 200 | $15.16 | Mid |
| EMA 20 | $22.71 | Mid |
| Opening Price | $0.2647 | Start Date | 2020-01-02 |
| Day Range | $0.2615 – $0.3119 | Market Cap | $15.54M |
| Monthly Range | $0.2307 – $0.4100 | 24h Volume | n/a |
| 90D Range | $0.1750 – $0.4100 | Circulating | n/a |
| 52W Range | $0.1750 – $1.91 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.